GIS W4 Colon Pharmacology Flashcards

1
Q

What critical metabolites produced during fermentation of fiber promote intestinal gluconeogenesis?

A

Proprionate and butyrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What critical metabolite produced during fermentation of fiber induces Treg cells to dampen inflammation?

A

Acetate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

In the small intestine, what cells on the villi absorb fluid?
What is the process driven by?

A

Cells at the tips of villi, Na+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

In the small intestine, what cells on the villi secrete fluid? What is the process driven by?

A

Cells in the crypts, CL-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Na+, K+ and Cl- are brought across the basolateral membrane via the _______ symporter

A

NKCC1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cations are transported back across the basolateral membrane via ______________________.

A

Na+/K+ ATPase and K+ channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cl- is moved across the apical membrane by _____.

d) Na+ and H2O follow via the ______________.

A

CFTR

paracellular route

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

13) Short Bowel Syndrome Treatment

b) Glucagon-like peptide 2 (GLP-2) analogue

A

TEDUGLUTIDE

binds to enteric neurons and endocrine cells  release of trophic hormones that increase mucosal epithelial growth  enhance fluid and nutrient absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

a) In the absence of nutrient absorption, Na+ enters colonocytes via a ________________

A

sodium channel (ENaC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

________ is a peptide hormone (released by goblet cells) that activates guanylyl cyclase C (GC-C) which increases cGMP

c) Increases in cGMP or cAMP increase flow through CFTR

A

GUANYLIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

This Diarrhea causes excess secretion of chloride and/or inhibition of NaCl transport across apical membrane
ii) Causes: infection, inflammation

A

a) Secretory diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

This diarrhea changes in luminal contents result in water being pulled from bloodstream
ii) Causes: Incomplete absorption

A

b) Osmotic diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

This drug affects chloride secretion

a) Activator of CIC-2

A

LUBIPROSTONE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

LINACLOTIDE MOA

A

This drug is an activator of GC-C

i) Activates guanylyl cyclase C  increase cGMP  activation of CFTR  increase Cl- secretion  retention of H2O in lumen  looser stool

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

CROFELEMER MOA

A

This drug is an inhibitor of CFTR

i) Voltage-independent inhibition of CFTR (and one other chloride channel)  decrease Cl- secretion  increase absorption of H2O from lumen  firmer stool

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

OCTREOTIDE MOA

A

This drug is a Somatostatin analogue

ii) Multiple effects on GI tract:
(1) 1) decreases 5HT-stimulated, cGMP-dependent Cl- secretion
(2) 2) decreased NT/hormone release (esp. 5-HT) 3) low doses increase motility, high doses decrease motility

17
Q

BISMUTH SUBSALICYLATE MOA

A

Cox inhibitor

i) Salicylate  decreased prostaglandin synthesis  decreased cAMP  decreased Cl- secretion  increased absorption of H2O from lumen  firmer stool

18
Q

LUBIPROSTONE MOA

A

i) Increased Cl- secretion –> retention of H2O in lumen –> looser stool

19
Q

LACTULOSE, MAGNESIUM HYDROXIDE, SODIUM PHOSPHATE, POLYETHYLENE GLYCOL

MOA

A

b) Osmotic cathartics

i) Not absorbed  increased retention of H2O in lumen due to osmosis  looser stool

20
Q

specifically decreases plasma ammonia concentrations –> used to treat portal systemic encephalopathy

A

ii) LACTULOSE

21
Q

i) CHOLESTYRAMINE, COLESTIPOL

MOA

A

Bile acid binding resins

(1) decrease reabsorption of bile salts (Crohn’s disease, resection of terminal ileum)  secretory diarrhea

22
Q

These SSRIs are effective treatments for constipation-predominant IBS

A

FLUOXETINE, PAROXETINE, SERTALINE

ii) decrease reuptake 5-HT into ECL cells  increased 5-HT in the synapse
 increase primary afferent activity  increase peristalsis

23
Q

Bulk laxatives MOA

A

increase the stimulation of mechanoreceptors

ii) Attract water and increase stool mass

24
Q

DIETARY FIBER, METHYLCELLULOSE, PSYLLIUM are classified as…

A

BULK LAXATIVES:

25
f) Contact cathartics MOA
are thought to stimulate the peristaltic reflex
26
ANTHRAQUINONE DERIVATIVES, BISACODYL, and CASTOR OIL are classified as...
CONTACT (IRRITANT) CATHARTICS
27
___________is a prodrug; must be converted to ricinoleic acid (1) Acts on both the small and large intestine  shorter latency and more significant side effects
CASTOR OIL
28
This 5-HT3 antagonist decreases gastric motility
ALOSETRON
29
TEGASEROD and CISAPRIDE MOA
5-HT4 agonists increase gastric motility Activation of presynaptic receptors  increases NT release from myenteric neurons  increases peristalsis
30
DOMPERIDONE and METOCLOPRAMIDE MOA
D2 receptor antagonists Inhibition of dopamine inhibition  increase actions of ACh in gut (i.e., they are cholinomimetics)  increase motility in entire gut (i.e., they are prokinetic)
31
DIPHENOXYLATE and LOPERAMIDE MOA
Opiates: decrease motility and secretion
32
ALVIMOPAN and METHYLNALOXONE MOA
μ receptor antagonists Selective antagonists that don’t cross the BBB  increase gastric motility
33
Drugs directly affecting cholinergic function are NOT used to treat diarrhea or constipation, but what are TWO EXCEPTIONS
i) TRICYCLIC ANTIDEPRESSANTS (AMITRIPTYLINE, DESIPRAMINE) and ii) ATROPINE
34
Prokinetics
(1) D2 receptor antagonists: DOMPERIDONE (*restricted use), METOCLOPRAMIDE (2) Macrolides: ERYTHROMYCIN (3) 5HT4 Agonists: CISAPRIDE (*restricted use)
35
Antidiarrheals
ii) Opiates: LOPERAMIDE, DIPHENOXYLATE+ATROPINE (1) Multiple uses including traveler’s diarrhea iii) BABRs: CHOLESTYRAMINE, COLESTIPOL (1) Malabsorption of bile salts (Crohn’s disease, resection of terminal ileum iv) OCTREOTIDE: severe diarrhea due to dumping syndrome, short bowel syndrome, vagotomy, AIDS v) BISMUTH SUBSALYCILATE: traveller’s diarrhea vi) CREFELEMER: diarrhea due to AIDS